ArticleCost effectiveness and resource allocation : C/E2023
Cost-effectiveness of surgical treatment of thumb carpometacarpal joint arthritis: a value of information study.
Article in Cost effectiveness and resource allocation : C/E, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 16 citations in OpenAlex.
- Increased Surgical Costs Do Not Result in Improved Patient-Reported Outcomes: A Study of 173 Patients Who Underwent Thumb Carpometacarpal Joint Arthroplasty.Hand (New York, N.Y.) · 2026Article
- Reply: Cost-utility Analysis of Ligament Reconstruction Tendon Interposition versus Suture Suspension Arthroplasty for Thumb Osteoarthritis.Plastic and reconstructive surgery. Global open · 2026Article
- Cost-Utility Analysis of Ligament Reconstruction With Tendon Interposition Versus Suture Suspension Arthroplasty for Thumb Osteoarthritis.Plastic and reconstructive surgery. Global open · 2026Article
- The Diagnostic Utility of Lateral Thumb Radiographs in Detecting Thumb Carpometacarpal Arthritis.Journal of hand surgery global online · 2026Article
- Review
- Cost-Utility Analysis of Ligament Reconstruction Tendon Interposition Versus Suture Suspension Arthroplasty for Thumb Osteoarthritis.Plastic and reconstructive surgery. Global open · 2025Article
- Surgical Management of Thumb Carpometacarpal Osteoarthritis: A Systematic Review, Network Meta-analysis, and Longitudinal Analysis of Surgical Complications.Journal of hand surgery global online · 2025Article
- Case Report: Focused shockwave therapy (fESWT) in thumb carpometacarpal joint osteoarthritis: a single case study.Frontiers in rehabilitation sciences · 2025Article
- Suture Suspensionplasty Compared With Ligament Reconstruction and Tendon Interposition for Surgical Treatment of Thumb Carpometacarpal Arthritis.Journal of hand surgery global online · 2024Article
- Rhizarthrosis Part I: A Literature Review.Cureus · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThumb carpometacarpal (CMC) joint arthritis is one of the most prevalent arthritic conditions commonly treated with trapeziectomy alone or trapeziectomy with ligament reconstruction and tendon interposition (LRTI). We evaluate the cost-effectiveness and value of perfect and sample information of trapeziectomy alone, LRTI, and non-operative treatment.
methodsA societal perspective decision tree was modeled. To understand the value of future research in comparing quality-of-life after trapeziectomy, LRTI, and non-operative management we characterized uncertainty by fitting distributions to EQ-5D utility data published from the United Kingdom hand surgery registry. We used Monte Carlo simulation for the probabilistic sensitivity analysis and to evaluate the value of perfect and sample information.
resultsBoth trapeziectomy alone and LRTI were cost-effective compared to non-operative management ($2,540 and $3,511/QALY respectively). Trapeziectomy alone (base case total cost $8,251, QALY 14.08) was dominant compared to LRTI (base case total cost $8,798, QALY 13.34). However, probabilistic sensitivity analysis suggested there is a 12.5% chance LRTI may be preferred at a willingness-to-pay of $50,000/QALY. Sensitivity analysis revealed postoperative utilities are the most influential factors in determining cost-effectiveness. The value of perfect information was approximately $1,503/person. A study evaluating the quality-of-life of 1,000 patients in each arm undergoing trapeziectomy alone or LRTI could provide an expected $1,117 of information value. With approximately 40,000 CMC arthroplasties performed each year in the U.S., the annual value is close to $45 million.
conclusionsTrapeziectomy without LRTI appears to be the most cost-effective procedure in treating late-stage CMC arthritis and should be considered as first-line surgical treatment. There is substantial societal value in conducting additional research to better understand the relative quality-of-life improvements gained from these two common hand surgeries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.